CA
NZ
UK
AU
IND
US
…
Nephros, Inc., a commercial-stage company, develops and sells water filtration solutions for medical and commercial applications in the United States. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in foodservice and hospitality, and other healthcare facilities. The company also manufactures and sells water filters that enhance the taste and odor of water; reduce biofilm and scale build-up; and remove cysts, particulates, and lead from water systems. It markets its products to food service and hospitality sectors including quick-service restaurants, convenience stores, and restaurants. The company was incorporated in 1997 and is headquartered in South Orange, New Jersey.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Income before tax | 1.21M | 0.09M | -1.57M | -4.28M | -3.87M |
| Minority interest | - | - | -0.07M | -0.28M | -0.24M |
| Net income | 1.19M | 0.07M | -1.57M | -7.32M | -4.17M |
| Selling general administrative | 9.00M | 7.68M | 8.29M | 7.59M | 7.71M |
| Gross profit | 11.48M | 8.72M | 8.40M | 4.73M | 5.74M |
| Reconciled depreciation | 0.14M | 0.14M | 0.22M | 0.22M | 0.20M |
| Ebit | 1.21M | 0.09M | -1.57M | -4.33M | -4.33M |
| Ebitda | 1.35M | 0.23M | -1.36M | -4.04M | -4.11M |
| Depreciation and amortization | 0.14M | 0.14M | 0.21M | 0.30M | 0.23M |
| Operating income | 1.15M | 0.01M | -1.59M | -4.33M | -4.33M |
| Other operating expenses | 17.64M | 14.16M | 15.83M | 14.31M | 14.74M |
| Interest expense | 0.00M | 0.00M | 0.00M | 0.02M | 0.04M |
| Tax provision | 0.01M | 0.01M | 0.00M | - | - |
| Interest income | 0.14M | 0.09M | 0.04M | 0.01M | 0.01M |
| Net interest income | 0.14M | 0.09M | 0.04M | -0.01M | -0.03M |
| Income tax expense | 0.01M | 0.01M | 0.05M | 3.05M | 0.30M |
| Total revenue | 18.79M | 14.16M | 14.24M | 9.97M | 10.40M |
| Total operating expenses | 10.34M | 8.72M | 10.00M | 9.07M | 10.08M |
| Cost of revenue | 7.30M | 5.44M | 5.83M | 5.24M | 4.66M |
| Total other income expense net | 0.06M | 0.08M | 0.02M | 0.06M | 0.47M |
| Discontinued operations | - | - | - | -2.83M | -2.83M |
| Net income from continuing ops | 1.19M | 0.07M | -1.64M | -4.28M | -3.87M |
| Net income applicable to common shares | - | - | - | -7.38M | -4.11M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Total assets | 13.64M | 11.21M | 11.86M | 11.00M | 17.65M |
| Intangible assets | 0.32M | 0.56M | 0.65M | 0.82M | 2.07M |
| Other current assets | 0.18M | 0.14M | 0.13M | 0.19M | 0.23M |
| Total liab | 3.44M | 2.62M | 3.50M | 2.12M | 2.90M |
| Total stockholder equity | 10.20M | 8.59M | 8.36M | 5.59M | 11.70M |
| Other current liab | 1.46M | 0.52M | 0.79M | 0.28M | 0.44M |
| Common stock | 0.01M | 0.01M | 0.01M | 0.01M | 0.01M |
| Capital stock | 0.01M | 0.01M | 0.01M | 0.01M | 0.01M |
| Retained earnings | -143.14M | -144.33M | -144.41M | -142.83M | -135.72M |
| Good will | 0.76M | 0.76M | 0.76M | 0.76M | 0.76M |
| Other assets | - | - | - | 0.05M | 0.09M |
| Cash | 5.40M | 3.76M | 4.31M | 3.63M | 6.97M |
| Total current liabilities | 2.77M | 1.56M | 2.11M | 1.41M | 2.39M |
| Net debt | -4.34M | -2.35M | -2.47M | -2.54M | -5.85M |
| Short term debt | 0.39M | 0.35M | 0.45M | 0.39M | 0.61M |
| Short long term debt | - | - | - | 0.07M | 0.25M |
| Short long term debt total | 1.06M | 1.41M | 1.84M | 1.09M | 1.12M |
| Other stockholder equity | 153.33M | 152.91M | 152.75M | 148.41M | 147.35M |
| Property plant equipment | - | - | - | 1.10M | 1.10M |
| Total current assets | 11.22M | 8.30M | 8.40M | 8.26M | 13.63M |
| Net tangible assets | - | - | - | 4.01M | 8.86M |
| Net receivables | 2.41M | 1.78M | 1.50M | 1.29M | 1.64M |
| Long term debt | - | - | - | 0.00M | 0.10M |
| Inventory | 3.23M | 2.62M | 2.47M | 3.15M | 4.79M |
| Accounts payable | 0.91M | 0.65M | 0.87M | 0.74M | 1.33M |
| Accumulated other comprehensive income | - | - | 0.00M | - | 0.06M |
| Non currrent assets other | 0.21M | 0.05M | 0.09M | 0.05M | 0.09M |
| Non current assets total | 2.42M | 2.91M | 3.46M | 2.74M | 4.02M |
| Capital lease obligations | 1.06M | 1.41M | 1.84M | 1.02M | 0.78M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Investments | - | -0.05M | -0.07M | -0.14M | -0.09M |
| Change to liabilities | - | - | - | 0.00M | 0.91M |
| Total cashflows from investing activities | - | -0.05M | -0.07M | - | -0.09M |
| Net borrowings | -0.01M | -0.01M | -0.08M | - | -0.26M |
| Total cash from financing activities | -0.01M | -0.01M | -0.08M | 0.03M | 0.24M |
| Change to operating activities | - | - | - | - | -0.04M |
| Net income | 1.19M | 0.07M | -1.57M | -7.11M | -3.87M |
| Change in cash | 1.64M | -0.55M | 0.67M | -3.34M | -1.28M |
| Begin period cash flow | 3.76M | 4.31M | 3.63M | 6.97M | 8.25M |
| End period cash flow | 5.40M | 3.76M | 4.31M | 3.63M | 6.97M |
| Total cash from operating activities | 1.65M | -0.49M | 0.83M | -3.23M | -1.42M |
| Issuance of capital stock | - | - | - | - | 0.00M |
| Depreciation | 0.14M | 0.14M | 0.21M | 0.35M | 0.25M |
| Other cashflows from investing activities | - | 0.01M | - | - | - |
| Dividends paid | - | - | - | -0.28M | - |
| Change to inventory | -0.69M | -0.41M | 0.39M | 0.92M | 0.30M |
| Change to account receivables | -0.63M | -0.28M | -0.22M | 0.36M | -0.28M |
| Other cashflows from financing activities | -0.01M | - | -0.07M | 0.60M | 0.50M |
| Change to netincome | - | - | - | - | 1.55M |
| Capital expenditures | 0.00M | 0.06M | 0.07M | 0.14M | 0.04M |
| Change in working capital | -0.41M | -1.55M | 0.49M | 0.23M | 0.88M |
| Stock based compensation | 0.30M | 0.15M | 1.05M | 0.98M | 1.26M |
| Other non cash items | 0.43M | 0.70M | 0.65M | 2.31M | 0.32M |
| Free cash flow | 1.65M | -0.55M | 0.75M | -3.37M | -1.45M |
Sector: Healthcare Industry: Medical Instruments & Supplies
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| NEPH Nephros Inc |
-0.30 9.71% |
2.79 | 26.81 | - | 2.25 | 4.02 | 2.14 | 23.59 |
| ISRG Intuitive Surgical Inc |
-15.72 3.36% |
452.80 | 43.30 | 31.35 | 12.25 | 7.35 | 11.63 | 30.22 |
| ESLOF EssilorLuxottica Société anonyme |
2.75 1.29% |
215.85 | 44.84 | 27.62 | 4.07 | 2.49 | 3.71 | 16.04 |
| ESLOY Essilor International SA |
0.92 0.86% |
107.77 | 41.68 | 27.25 | 3.94 | 2.45 | 3.71 | 16.04 |
| BDX Becton Dickinson and Company |
-1.69 0.79% |
211.86 | 31.62 | 13.76 | 2.25 | 2.04 | 2.93 | 13.40 |
Nephros, Inc., a commercial-stage company, develops and sells water filtration solutions for medical and commercial applications in the United States. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in foodservice and hospitality, and other healthcare facilities. The company also manufactures and sells water filters that enhance the taste and odor of water; reduce biofilm and scale build-up; and remove cysts, particulates, and lead from water systems. It markets its products to food service and hospitality sectors including quick-service restaurants, convenience stores, and restaurants. The company was incorporated in 1997 and is headquartered in South Orange, New Jersey.
380 Lackawanna Place, South Orange, NJ, United States, 07079
201 343 5202
36
| Name | Title | Year Born |
|---|---|---|
| Mr. Andrew Astor | CEO, CFO, Pres & Director | 1957 |
| Ms. Joleen C. Turner | VP of Marketing & Bus. Devel. | NA |
| Vashone R. Thomas | VP of Quality, Regulatory, & HR | NA |
| Mr. Daron G. Evans | Chief Exec. Officer of Specialty Renal Products, Inc | 1974 |
| Mr. Greg Lucas | Pres of Aether Water Systems | NA |
| Mr. Robert Banks | President, CEO & Director | NA |
| Ms. Judy F. Krandel C.F.A. | Chief Financial Officer | 1965 |
| Mr. Alfred Vargas | Director of Operations | NA |
| Brianne McGuire | Director of Brand, Marketing & Business Development | NA |
| Vashone R. Thomas | Vice President of Quality, Regulatory, & Human Resources | NA |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.
Download a free report with stock ideas and industry insights for general information.
Download Free Report Now →
Basic Materials
+0.61%
Communication Services
-0.21%
Consumer Cyclical
-0.26%
Consumer Defensive
-0.37%
Energy
+0.23%
Financial Services
-0.43%
Financials
+0.39%
Healthcare
+0.88%
Industrials
+0.36%
Real Estate
-0.51%
Technology
+1.35%
Utilities
+0.19%
Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.
Portfolio
Watchlist
Please wait processing your request...